4D Molecular Therapeutics, Inc.
FDMT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001650648
In the last 90 days, 4D Molecular Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 157 institutions reported holding it in 13F filings for Q2 2026, worth $771.2M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in 4D Molecular Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 143
- −3 vs. Q1 2024
- Shares held
- 57.3M
- +1.01M (+1.8%) vs. Q1 2024
- Total value
- $1.20B
- −$589.6M (−32.9%) vs. Q1 2024
- New holders
- 29
- 54 more added
- Sold out
- 32
- 37 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FDMT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 157 | $771.2M |
| Q1 2026 | 153 | $471.4M |
| Q4 2025 | 153 | $400.5M |
| Q3 2025 | 134 | $343.2M |
| Q2 2025 | 121 | $149.9M |
| Q1 2025 | 126 | $139.8M |
| Q4 2024 | 146 | $260.6M |
| Q3 2024 | 140 | $629.2M |
| Q2 2024 | 143 | $1.20B |
| Q1 2024 | 147 | $1.79B |
| Q4 2023 | 111 | $859.8M |
| Q3 2023 | 110 | $533.6M |
| Q2 2023 | 100 | $745.3M |
| Q1 2023 | 94 | $522.3M |
| Q4 2022 | 96 | $621.9M |
| Q3 2022 | 88 | $210.4M |
| Q2 2022 | 90 | $181.7M |
| Q1 2022 | 80 | $395.3M |
| Q4 2021 | 77 | $541.8M |
| Q3 2021 | 63 | $515.1M |
| Q2 2021 | 56 | $400.0M |
| Q1 2021 | 64 | $664.8M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding 4D Molecular Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nuveen Asset Management, LLC | 123,468 | $2.59M | 0.00% | +14,718+13.5% | Added |
| Deutsche Bank AG | 124,339 | $2.61M | 0.00% | +2,479+2.0% | Added |
| Jane Street Group, LLC | 133,525 | $2.80M | 0.00% | +104,014+352.5% | Added |
| Zimmer Partners, LP | 138,800 | $2.91M | 0.06% | 00.0% | Unchanged |
| Perigon Wealth Management, LLC | 146,170 | $3.07M | 0.09% | +200.0% | Added |
| Bank of New York Mellon Corp | 169,413 | $3.56M | 0.00% | +38,015+28.9% | Added |
| Kennedy Capital Management, Inc. | 176,765 | $3.71M | 0.08% | +39,994+29.2% | Added |
| Wellington Management Group LLP | 179,444 | $3.77M | 0.00% | +9,796+5.8% | Added |
| Marshall Wace, LLP | 185,866 | $3.90M | 0.01% | −71,880−27.9% | Reduced |
| Bank of America Corp | 227,599 | $4.78M | 0.00% | +108,042+90.4% | Added |
| Sphera Funds Management Ltd. | 242,526 | $5.09M | 0.83% | +80,365+49.6% | Added |
| Sofinnova Investments, Inc. | 271,155 | $5.69M | 0.36% | +72,969+36.8% | Added |
| Charles Schwab Investment Management Inc | 337,865 | $7.09M | 0.00% | +35,660+11.8% | Added |
| Opaleye Management Inc. | 345,750 | $7.26M | 1.66% | +1,627+0.5% | Added |
| JPMorgan Chase & Co | 345,773 | $7.26M | 0.00% | −56,768−14.1% | Reduced |
| Decheng Capital LLC | 347,835 | $7.30M | 2.24% | 00.0% | Unchanged |
| Panagora Asset Management Inc | 354,857 | $7.45M | 0.04% | +252,789+247.7% | Added |
| Voloridge Investment Management, LLC | 361,697 | $7.59M | 0.03% | −19,382−5.1% | Reduced |
| Northern Trust Corp | 367,479 | $7.71M | 0.00% | −6,703−1.8% | Reduced |
| Braidwell LP | 369,458 | $7.75M | 0.24% | −683,027−64.9% | Reduced |
| Assenagon Asset Management S.A. | 456,267 | $9.58M | 0.02% | +25,711+6.0% | Added |
| Eagle Health Investments LP | 462,911 | $9.72M | 1.74% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 532,742 | $11.2M | 0.00% | −216,250−28.9% | Reduced |
| Healthcare of Ontario Pension Plan Trust Fund | 706,000 | $14.8M | 0.04% | +65,000+10.1% | Added |
| Casdin Capital, LLC | 800,000 | $16.8M | 1.28% | 00.0% | Unchanged |
| ArrowMark Colorado Holdings LLC | 850,201 | $17.8M | 0.21% | −228,124−21.2% | Reduced |
| Eventide Asset Management, LLC | 881,157 | $18.5M | 0.32% | +105,043+13.5% | Added |
| FMR LLC | 1,016,223 | $21.3M | 0.00% | +47,341+4.9% | Added |
| Geode Capital Management, LLC | 1,060,891 | $22.3M | 0.00% | +188,228+21.6% | Added |
| Redmile Group, LLC | 1,073,435 | $22.5M | 1.36% | −187,992−14.9% | Reduced |
| Novo Holdings A/S | 1,400,000 | $29.4M | 1.58% | 00.0% | Unchanged |
| Morgan Stanley | 1,460,234 | $30.7M | 0.00% | −89,492−5.8% | Reduced |
| Polar Capital Holdings Plc | 1,744,857 | $36.6M | 0.22% | −53,635−3.0% | Reduced |
| State Street Corp | 2,079,276 | $43.6M | 0.00% | −98,954−4.5% | Reduced |
| Vanguard Group Inc | 2,528,180 | $53.1M | 0.00% | +188,237+8.0% | Added |
| Viking Global Investors LPSuperinvestorViking Global Investors | 2,934,914 | $61.6M | 0.24% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 3,196,762 | $67.1M | 0.04% | −6820.0% | Reduced |
| BVF Inc | 3,922,413 | $82.3M | 2.31% | 00.0% | Unchanged |
| Deep Track Capital, LP | 4,061,401 | $85.2M | 2.55% | +1,026,948+33.8% | Added |
| Goldman Sachs Group Inc | 4,134,254 | $86.8M | 0.02% | +1,076,405+35.2% | Added |
| VR Adviser, LLC | 4,400,000 | $92.4M | 5.88% | 00.0% | Unchanged |
| BlackRock Inc. | 4,896,897 | $102.8M | 0.00% | +612,349+14.3% | Added |
| Ra Capital Management, L.P. | 5,098,211 | $107.0M | 1.42% | +46,700+0.9% | Added |
| LMR Partners LLP | 0 | $0 | 0.00% | −487,533−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −269,000−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −113,590−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −96,225−100.0% | Sold out |
| Ghisallo Capital Management LLC | 0 | $0 | 0.00% | −80,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −69,833−100.0% | Sold out |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 0 | $0 | 0.00% | −62,500−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −54,219−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −29,895−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −20,020−100.0% | Sold out |
| Concurrent Investment Advisors, LLC | 0 | $0 | 0.00% | −17,325−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −15,818−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −10,788−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −10,472−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −8,821−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −8,634−100.0% | Sold out |
| Vident Advisory, LLC | 0 | $0 | 0.00% | −8,600−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −7,487−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −7,458−100.0% | Sold out |
| DnB Asset Management AS | 0 | $0 | 0.00% | −7,363−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −7,351−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −7,308−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −4,741−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −4,583−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −3,457−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −2,164−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −142−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Rothschild Investment LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |